Contact: research@protoquiz.com

Statewide

Oklahoma State Department of Health

May be outdated246 dose entries38 drugs4 documentsOKeffective 2018-01-01100% machine-parsed of 246

The current listed document is more than 24 months old and may be outdated.

Drugs and doses38

A–C Activated Charcoal, Adenosine, Albuterol, Amiodarone, Atropine, Calcium Chloride6

Activated Charcoal

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 g/kg PO not captured standing page 410
Other peds 1 g/kg PO not captured standing page 410

Adenosine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 12 mg IV not captured standing page 411
Other adult 12 mg IV not captured standing pages 151, 411

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 5 mg NEB not captured standing page 325
Cyanide poisoning peds 2.5 mg NEB not captured standing page 325
Other adult 5 mg NEB not captured standing page 68
Other adult 5 mg NEB not captured standing page 70
Other adult 5 mg NEB not captured standing page 72
Other adult 5 mg NEB not captured standing page 221
Other adult 5 mg NEB not captured standing page 225
Other adult 5 mg NEB not captured standing pages 72, 413
Other peds 2.5 mg NEB not captured standing page 68
Other peds 2.5 mg NEB not captured standing page 70
Other peds 2.5 mg NEB not captured standing page 221
Other peds 2.5 mg NEB not captured standing page 225

Amiodarone

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 150 mg IV/IO not captured standing pages 122, 415
Other adult 150 mg IV not captured standing pages 151, 415
Other adult 150 mg IV/IO not captured standing pages 122, 415
Other adult 300 mg IV/IO not captured standing pages 122, 415
Other peds 5 mg/kg IV/IO not captured standing pages 122, 415
VF / pulseless VT adult 300 mg IV/IO not captured standing pages 122, 415
VF / pulseless VT peds 5 mg/kg IV/IO not captured standing pages 122, 415

Atropine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 0.5 mg IV/IO not captured standing pages 145, 417
Bradycardia peds 0.02 mg/kg IV/IO not captured standing pages 145, 417
Bradycardia peds 0.02 mg/kg IV/IO not captured standing pages 145, 417
Nerve agent exposure peds 0.05 mg/kg IM not captured standing page 430
Organophosphate poisoning adult 2 mg IV/IO/IM not captured standing pages 215, 417, 418
Organophosphate poisoning peds 0.05 mg/kg IV/IO/IM not captured standing pages 215, 417, 418
Other adult 1 mg IV not captured standing page 400
Other adult 2 mg IM not captured standing page 400
Other adult 2.1 mg IM not captured standing page 430
Other peds 0.05 mg/kg IV/IO/IM not captured standing pages 215, 418

Calcium Chloride

IndicationPopulationDoseRouteRepeatStandingSource
Beta-blocker / calcium-channel-blocker overdose adult 10 mg/kg IV/IO not captured standing pages 126, 419
Beta-blocker / calcium-channel-blocker overdose peds 10 mg/kg IV/IO not captured standing pages 126, 419
Hyperkalemia adult 10 mg/kg IV/IO not captured standing pages 126, 419
Hyperkalemia peds 10 mg/kg IV/IO not captured standing pages 126, 419
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl8

Dextrose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 1 mL/kg IV not captured standing pages 65, 126, 188, 196, 198, 201, 203, 420, 421
Hypoglycemia adult 25 g IV not captured standing page 422
Hypoglycemia peds 0.5–1 g/kg IV not captured standing page 422
Hypoglycemia peds 2 mL/kg IV not captured standing pages 65, 126, 188, 196, 198, 201, 203, 420, 421
Other adult 25 g IV not captured standing page 422
Other adult 1 mL/kg IV not captured standing pages 65, 126, 188, 196, 198, 201, 203, 421
Other peds 0.5–1 g/kg IV not captured standing page 422
Other peds 7.5 g PO not captured standing pages 188, 198, 201, 203
Other peds 1 mL/kg IV not captured standing pages 65, 126, 188, 196, 198, 201, 203, 421

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5 mg IV/IO/IM not captured standing pages 209, 424
Agitation peds 0.1 mg/kg IV/IO/IM not captured standing pages 209, 424
Dystonic reaction adult 5 mg IV/IM not captured standing pages 201, 424
Dystonic reaction peds 0.1 mg/kg IV/IM not captured standing pages 201, 424
Other adult 0.1 mg/kg IV/IO not captured standing page 47
Other adult 2.5 mg IV not captured standing page 424
Other adult 2.5–5 mg IV not captured standing pages 215, 424
Other adult 5 mg IV/IO/IM not captured standing pages 265, 424
Other peds 0.1 mg/kg IV/IO/IM not captured standing pages 265, 424
Seizure adult 5 mg IV/IO/IM not captured standing pages 196, 424
Seizure peds 0.1 mg/kg IV/IO/IM not captured standing pages 196, 424

Diltiazem

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.25 mg/kg IV not captured standing page 425
Other adult 0.25 mg/kg IV not captured standing pages 151, 425

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Dystonic reaction adult 50 mg IV/IM not captured standing pages 201, 426
Dystonic reaction peds 1 mg/kg IV/IM not captured standing pages 201, 426
Other adult 50 mg IV/IM not captured standing pages 221, 426
Other adult 50 mg IV/IM not captured standing pages 225, 426
Other peds 1 mg/kg IV/IM not captured standing pages 221, 426
Other peds 1 mg/kg IV/IM not captured standing pages 225, 426

Dopamine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 5–20 mcg/kg IV/IO not captured standing pages 74, 129, 232, 427, 428
Other adult 5–20 mcg/kg IV/IO not captured standing pages 74, 427, 428
Other adult 5–20 mcg/kg IV not captured standing pages 143, 427

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis peds 0.01 mg/kg (max 0.5 mg) IV/IO not captured standing pages 221, 223, 225, 432
Asthma / bronchospasm adult 0.3 mg IM not captured standing pages 70, 431
Asthma / bronchospasm peds 0.01 mg/kg IM not captured standing pages 70, 431
Asystole / PEA adult 1 mg IV/IO not captured standing pages 120, 124, 432
Asystole / PEA adult 1 mg IV/IO not captured standing pages 124, 432
Asystole / PEA peds 0.01 mg/kg IV/IO not captured standing pages 120, 124, 432
Asystole / PEA peds 0.01 mg/kg IV/IO not captured standing pages 124, 432
Asystole / PEA peds 0.01 mg/kg IV/IO not captured standing pages 120, 432
Bradycardia peds 0.01 mg/kg IV/IO not captured standing page 432
Other adult 0.3 mg IM not captured standing pages 70, 433, 434
Other adult 0.5 mg IM not captured standing pages 221, 225, 431
Other adult 0.5 mg IM not captured standing pages 70, 431
Other peds 0.01 mg/kg IM not captured standing pages 221, 225, 431
Other peds 0.01 mg/kg IV/IO not captured standing pages 221, 225, 432
Other peds 0.01 mg/kg (max 0.3 mg) IM not captured standing pages 70, 431
Other peds 0.15 mg IM not captured standing pages 70, 433, 434
VF / pulseless VT adult 1 mg IV/IO not captured standing pages 122, 124, 432
VF / pulseless VT peds 0.01 mg/kg IV/IO not captured standing pages 122, 124, 432

Etomidate

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.3 mg/kg IV/IO not captured standing pages 47, 435

Fentanyl

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 1 mcg/kg IV/IM/IN not captured standing pages 143, 437
ACS / chest pain peds 1 mcg/kg IV/IM/IN not captured standing pages 143, 437
Other adult 0.5 mcg/kg IV/IM/IN not captured standing pages 136, 437
Other adult 1 mcg/kg IV/IM/IN not captured standing pages 136, 437
Other adult 1 mcg/kg IV/IM/IN not captured standing pages 223, 437
Other adult 1 mcg/kg IV/IM/IN not captured standing pages 230, 437
Other adult 1 mcg/kg IV/IM/IN not captured standing pages 267, 437
Other adult 1 mcg/kg IV/IM/IN not captured standing pages 269, 437
Other adult 1 mcg/kg IV/IM/IN not captured standing pages 271, 437
Other adult 1 mcg/kg IV/IM/IN not captured standing pages 223, 230, 236, 267, 269, 271, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 136, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 223, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 230, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 267, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 269, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 271, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 136, 437
Other peds 1 mcg/kg IV/IM/IN not captured standing pages 223, 230, 236, 267, 269, 271, 437
Mild to moderate pain adult 1 mcg/kg IV/IM/IN not captured standing pages 236, 437
Mild to moderate pain peds 1 mcg/kg IV/IM/IN not captured standing pages 236, 437
G–L Glucagon, Haloperidol, Hydralazine, Hydromorphone, Hydroxocobalamin, Ipratropium, Labetalol, Lidocaine, Lidocaine Viscous Gel, Lorazepam10

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Beta-blocker / calcium-channel-blocker overdose adult 1 mg IV/IO not captured standing pages 215, 439
Beta-blocker / calcium-channel-blocker overdose peds 0.5 mg IV/IO not captured standing pages 215, 439
Hypoglycemia adult 1 mg IM not captured standing pages 65, 188, 196, 198, 201, 203, 215, 439
Hypoglycemia peds 0.5 mg IM not captured standing pages 65, 188, 196, 198, 201, 203, 215, 439
Other adult 1 mg IM not captured standing pages 65, 126, 188, 196, 198, 201, 203, 215, 342, 438, 439
Other peds 0.5 mg IM not captured standing pages 65, 126, 188, 196, 198, 201, 203, 439
Other peds 1 mg IM not captured standing pages 65, 126, 188, 196, 198, 201, 203, 215, 342, 438, 439

Haloperidol

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5 mg IM not captured standing pages 209, 442

Hydralazine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 10 mg IV not captured standing pages 165, 443

Hydromorphone

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.5–1 mg IV not captured standing pages 143, 445
Burns adult 0.5–1 mg IV not captured standing pages 291, 445
Crush injury adult 0.5–1 mg IV not captured standing pages 289, 445
Other adult 0.25 mg IV not captured standing pages 136, 143, 445
Other adult 0.5–1 mg IV not captured standing pages 136, 445
Other adult 0.5–1 mg IV not captured standing pages 223, 445
Other adult 0.5–1 mg IV not captured standing pages 230, 445
Other adult 0.5–1 mg IV not captured standing pages 236, 445
Other adult 0.5–1 mg IV not captured standing pages 267, 445
Other adult 0.5–1 mg IV not captured standing pages 269, 445
Other adult 0.5–1 mg IV not captured standing pages 271, 445
Other adult 0.5–1 mg IV not captured standing pages 279, 445
Other adult 0.5–1 mg IV not captured standing pages 287, 445
Other adult 0.5–1 mg IV not captured standing pages 318, 445
Other adult 0.5–1 mg IV not captured standing pages 344, 445
Other adult 0.5–1 mg IV not captured standing pages 223, 230, 236, 267, 269, 271, 279, 445
Other peds 0.01 mg/kg IV not captured standing pages 136, 143, 445
Other peds 0.01 mg/kg IV not captured standing pages 223, 230, 236, 267, 269, 271, 279, 445

Hydroxocobalamin

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 5 g IV not captured standing page 446
Cyanide poisoning peds 70 mg/kg IV not captured standing page 446

Ipratropium

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.5 mg NEB not captured standing pages 447, 448
Other adult 0.5 mg NEB not captured standing pages 72, 447
Other peds 0.25 mg NEB not captured standing pages 447, 448

Labetalol

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 20 mg IV not captured standing pages 165, 443, 449
Other peds 0.3 mg/kg IV not captured standing pages 165, 443, 449

Lidocaine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 mg/kg IV/IO not captured standing page 452
Other adult 1 mg/kg IO not captured standing pages 248, 251, 452
Other adult 1 mg/kg IO not captured standing pages 248, 251, 452
Other peds 1 mg/kg IO not captured standing pages 248, 251, 452
Other peds 1 mg/kg IO not captured standing pages 248, 251, 452

Lidocaine Viscous Gel

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 1–2 mL TOP not captured standing page 453

Lorazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 2 mg IV/IO/IM not captured standing pages 209, 455
Agitation peds 0.1 mg/kg IV/IO/IM not captured standing pages 209, 455
Dystonic reaction adult 2 mg IV/IM not captured standing pages 201, 455
Dystonic reaction peds 0.1 mg/kg IV/IM not captured standing pages 201, 455
Other adult 0.1 mg/kg IV/IO not captured standing page 47
Other adult 1–2 mg IV/IM not captured standing page 455
Other adult 1 mg IV/IO/IM not captured standing pages 265, 455
Other peds 0.1 mg/kg IV/IO/IM not captured standing pages 265, 455
Seizure adult 2 mg IV/IO/IM not captured standing pages 196, 454, 455
Seizure peds 0.1 mg/kg IV/IO/IM not captured standing pages 196, 454, 455
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nerve Agent Antidote Kit, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose10

Magnesium Sulfate

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 g IV/IO not captured standing pages 122, 456
Other adult 1 g IV/IO not captured standing pages 151, 456
Other adult 1 g IV/IO not captured standing pages 338, 456
Other adult 2 g IV not captured standing pages 70, 456

Methylprednisolone

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 125 mg IV/IM not captured standing pages 70, 458
Asthma / bronchospasm peds 2 mg/kg IV/IM not captured standing pages 70, 458
Other adult 125 mg IV/IM not captured standing pages 72, 458
Other adult 125 mg IV/IM not captured standing pages 221, 225, 458
Other adult 125 mg IV not captured standing pages 70, 458
Other peds 2 mg/kg IV/IM not captured standing pages 221, 225, 458
Other peds 2 mg/kg IV not captured standing pages 70, 458
Other peds 2 mg/kg IV/IM not captured standing pages 221, 458

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 0.1 mg/kg IV/IO/IM/IN not captured standing pages 209, 460
Agitation peds 0.1 mg/kg IV/IO/IM/IN not captured standing pages 209, 460
Dystonic reaction adult 2.5 mg IV/IM/IN not captured standing pages 201, 460
Dystonic reaction adult 2.5 mg IV/IM/IN not captured standing pages 201, 460
Dystonic reaction peds 0.1 mg/kg IV/IM/IN not captured standing pages 201, 460
Dystonic reaction peds 0.1 mg/kg IV/IM/IN not captured standing pages 201, 460
Other adult 0.1 mg/kg IV/IO not captured standing pages 47, 435
Other adult 0.1 mg/kg IV/IO not captured standing pages 47, 435
Other adult 0.1 mg/kg IV/IO not captured standing pages 129, 459
Other adult 0.1 mg/kg IV/IO not captured standing pages 153, 460
Other adult 0.1 mg/kg IV/IM/IN not captured standing pages 209, 460
Other adult 5 mg IV/IO/IM/IN not captured standing pages 265, 460
Other peds 0.1 mg/kg IV/IO not captured standing pages 129, 459
Other peds 0.1 mg/kg IV/IO/IM/IN not captured standing pages 265, 460
Procedural sedation adult 2–5 mg IV not captured standing pages 147, 459
Seizure adult 0.1 mg/kg IV/IO/IM/IN not captured standing pages 196, 460
Seizure peds 0.1 mg/kg IV/IO/IM/IN not captured standing pages 196, 460

Morphine

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 2–4 mg IV not captured standing pages 143, 462
Other adult 2–4 mg IV not captured standing pages 223, 230, 236, 267, 269, 271, 462
Other adult 2 mg IV not captured standing pages 136, 143, 462
Other adult 2–4 mg IV not captured standing pages 136, 462
Other adult 2–4 mg IV not captured standing pages 223, 462
Other adult 2–4 mg IV not captured standing pages 230, 462
Other adult 2–4 mg IV not captured standing pages 267, 462
Other adult 2–4 mg IV not captured standing pages 269, 462
Other adult 2–4 mg IV not captured standing pages 271, 462
Other peds 0.1 mg/kg IV not captured standing pages 136, 143, 462
Other peds 0.1 mg/kg IV not captured standing pages 223, 230, 236, 267, 269, 271, 462
Mild to moderate pain adult 2–4 mg IV not captured standing pages 236, 462

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.5 mg IV/IO/IN not captured standing pages 65, 126, 188, 198, 215, 463, 464
Other peds 0.5 mg IV/IO/IN not captured standing pages 65, 126, 188, 198, 215, 463, 464
Other peds 0.5 mg IV/IO/IN not captured standing pages 65, 126, 188, 198, 215, 463, 464

Nerve Agent Antidote Kit

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 2.1 mg IM not captured standing pages 402, 430
Nerve agent exposure peds 0.05 mg/kg IM not captured standing pages 402, 430

Nitroglycerin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.4 mg SL not captured standing pages 143, 466
CHF / pulmonary edema adult 0.4 mg SL not captured standing pages 74, 466
Other adult 0.4 mg SL not captured standing pages 136, 466
Other adult 0.4 mg SL not captured standing pages 165, 466
Other adult 0.4 mg SL not captured standing pages 74, 466

Norepinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2–4 mcg IV not captured standing pages 74, 467, 468
Other adult 2–4 mcg IV not captured standing pages 129, 467, 468
Other adult 2–4 mcg IV not captured standing pages 143, 467, 468
Other adult 2–4 mcg IV not captured standing pages 232, 467, 468
Other adult 2–4 mcg IV not captured standing pages 238, 467, 468
Other adult 2–4 mcg IV/IO not captured standing pages 74, 467, 468

Ondansetron

IndicationPopulationDoseRouteRepeatStandingSource
Fever adult 4 mg IV not captured standing pages 232, 469
Fever peds 0.1 mg/kg IV not captured standing pages 232, 469
Other adult 4 mg IV not captured standing pages 223, 469
Other adult 4 mg IV not captured standing pages 230, 469
Other adult 4 mg IV not captured standing pages 344, 469
Other adult 4 mg ODT not captured standing pages 223, 230, 232, 344, 469
Other peds 0.1 mg/kg IV not captured standing pages 223, 469
Other peds 0.1 mg/kg IV not captured standing pages 230, 469
Other peds 0.1 mg/kg IV not captured standing pages 344, 469
Other peds 4 mg ODT not captured standing pages 223, 230, 232, 344, 469

Oral Glucose

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 15 g PO/SL not captured standing pages 188, 198, 201, 203, 238, 342, 440, 441
Other peds 7.5 g PO not captured standing pages 188, 198, 201, 203, 441
Other peds 7.5 g PO/SL not captured standing pages 188, 198, 201, 203, 238, 342, 440, 441
P–R Phentolamine, Phenylephrine, Pralidoxime3

Phentolamine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 5–10 mg not captured not captured standing page 468

Phenylephrine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2–4 spray IN not captured standing pages 234, 472
Other adult 2–4 spray IN not captured standing page 472
Other adult 2 spray IN not captured standing page 234
Other adult 2 spray IN not captured standing pages 49, 472
Other peds 2–4 spray IN not captured standing pages 234, 472
Other peds 2–4 spray IN not captured standing page 472
Other peds 2 spray IN not captured standing page 234
RSI induction adult 2 spray IN not captured standing page 49

Pralidoxime

IndicationPopulationDoseRouteRepeatStandingSource
Organophosphate poisoning adult 600 mg IM not captured standing pages 215, 473
Organophosphate poisoning peds 15 mg/kg IM not captured standing pages 215, 473
Other adult 600 mg IM not captured standing pages 215, 430, 473
Other peds 600 mg IM not captured standing pages 215, 430, 473
S–Z Sodium Bicarbonate1

Sodium Bicarbonate

IndicationPopulationDoseRouteRepeatStandingSource
Hyperkalemia adult 1 mEq/kg IV/IO not captured standing pages 126, 474
Hyperkalemia peds 1 mEq/kg IV/IO not captured standing pages 126, 474
Other adult 1 mEq/kg IV/IO not captured standing pages 126, 474
Other peds 1 mEq/kg IV/IO not captured standing pages 126, 474
Tricyclic overdose adult 1 mEq/kg IV/IO not captured standing pages 126, 474
Tricyclic overdose peds 1 mEq/kg IV/IO not captured standing pages 126, 474
Cite this

Oklahoma State Department of Health, United States EMS Protocol Census. 246 dose entries, effective 2018-01-01.

https://protoquiz.com/census/agencies/oklahoma-state-department-of-health/

Outdated or wrong? Fix or remove itAll Oklahoma agenciesMethodologyData licenseStudy these protocols in the app

The census is free and not for sale. Only public agencies are named.

Training reference compiled from published protocols. Not a clinical order. Verify with your agency and medical director.